Serveur d'exploration sur la maladie de Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis

Identifieur interne : 001483 ( Main/Curation ); précédent : 001482; suivant : 001484

Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis

Auteurs : Claire L. Tomlinson [Royaume-Uni] ; Smitaa Patel [Royaume-Uni] ; Charmaine Meek [Royaume-Uni] ; Clare P. Herd [Royaume-Uni] ; Carl E. Clarke [Royaume-Uni] ; Rebecca Stowe [Royaume-Uni] ; Laila Shah [Royaume-Uni] ; Catherine Sackley [Royaume-Uni] ; Katherine H O. Deane [Royaume-Uni] ; Keith Wheatley [Royaume-Uni] ; Natalie Ives [Royaume-Uni]

Source :

RBID : ISTEX:76F28FD69674A9085206DEA896CE201F5FDB97DD

Abstract

Objective To assess the effectiveness of physiotherapy compared with no intervention in patients with Parkinson’s disease. Design Systematic review and meta-analysis of randomised controlled trials. Data sources Literature databases, trial registries, journals, abstract books, and conference proceedings, and reference lists, searched up to the end of January 2012. Review methods Randomised controlled trials comparing physiotherapy with no intervention in patients with Parkinson’s disease were eligible. Two authors independently abstracted data from each trial. Standard meta-analysis methods were used to assess the effectiveness of physiotherapy compared with no intervention. Tests for heterogeneity were used to assess for differences in treatment effect across different physiotherapy interventions used. Outcome measures were gait, functional mobility and balance, falls, clinician rated impairment and disability measures, patient rated quality of life, adverse events, compliance, and economic analysis outcomes. Results 39 trials of 1827 participants met the inclusion criteria, of which 29 trials provided data for the meta-analyses. Significant benefit from physiotherapy was reported for nine of 18 outcomes assessed. Outcomes which may be clinically significant were speed (0.04 m/s, 95% confidence interval 0.02 to 0.06, P<0.001), Berg balance scale (3.71 points, 2.30 to 5.11, P<0.001), and scores on the unified Parkinson’s disease rating scale (total score −6.15 points, −8.57 to −3.73, P<0.001; activities of daily living subscore −1.36, −2.41 to −0.30, P=0.01; motor subscore −5.01, −6.30 to −3.72, P<0.001). Indirect comparisons of the different physiotherapy interventions found no evidence that the treatment effect differed across the interventions for any outcomes assessed, apart from motor subscores on the unified Parkinson’s disease rating scale (in which one trial was found to be the cause of the heterogeneity). Conclusions Physiotherapy has short term benefits in Parkinson’s disease. A wide range of physiotherapy techniques are currently used to treat Parkinson’s disease, with little difference in treatment effects. Large, well designed, randomised controlled trials with improved methodology and reporting are needed to assess the efficacy and cost effectiveness of physiotherapy for treating Parkinson’s disease in the longer term.

Url:
DOI: 10.1136/bmj.e5004

Links toward previous steps (curation, corpus...)


Links to Exploration step

ISTEX:76F28FD69674A9085206DEA896CE201F5FDB97DD

Le document en format XML

<record>
<TEI wicri:istexFullTextTei="biblStruct">
<teiHeader>
<fileDesc>
<titleStmt>
<title>Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis</title>
<author>
<name sortKey="Tomlinson, Claire L" sort="Tomlinson, Claire L" uniqKey="Tomlinson C" first="Claire L" last="Tomlinson">Claire L. Tomlinson</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>E-mail: c.l.smith.1@bham.ac.uk</mods:affiliation>
<country wicri:rule="url">Royaume-Uni</country>
</affiliation>
</author>
<author>
<name sortKey="Patel, Smitaa" sort="Patel, Smitaa" uniqKey="Patel S" first="Smitaa" last="Patel">Smitaa Patel</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Meek, Charmaine" sort="Meek, Charmaine" uniqKey="Meek C" first="Charmaine" last="Meek">Charmaine Meek</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Herd, Clare P" sort="Herd, Clare P" uniqKey="Herd C" first="Clare P" last="Herd">Clare P. Herd</name>
<affiliation wicri:level="4">
<mods:affiliation>School of Clinical and Experimental Medicine, College of Medicine and Dental Sciences, University of Birmingham</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
<orgName type="university">Université de Birmingham</orgName>
</affiliation>
</author>
<author>
<name sortKey="Clarke, Carl E" sort="Clarke, Carl E" uniqKey="Clarke C" first="Carl E" last="Clarke">Carl E. Clarke</name>
<affiliation wicri:level="4">
<mods:affiliation>School of Clinical and Experimental Medicine, College of Medicine and Dental Sciences, University of Birmingham</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
<orgName type="university">Université de Birmingham</orgName>
</affiliation>
<affiliation wicri:level="3">
<mods:affiliation>Department of Neurology, Sandwell and West Birmingham Hospitals NHS Trust, City Hospital, Birmingham</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
<wicri:orgArea>Department of Neurology, Sandwell and West Birmingham Hospitals NHS Trust, City Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Stowe, Rebecca" sort="Stowe, Rebecca" uniqKey="Stowe R" first="Rebecca" last="Stowe">Rebecca Stowe</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Shah, Laila" sort="Shah, Laila" uniqKey="Shah L" first="Laila" last="Shah">Laila Shah</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Sackley, Catherine" sort="Sackley, Catherine" uniqKey="Sackley C" first="Catherine" last="Sackley">Catherine Sackley</name>
<affiliation wicri:level="1">
<mods:affiliation>University of East Anglia, Norwich, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of East Anglia, Norwich</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Deane, Katherine H O" sort="Deane, Katherine H O" uniqKey="Deane K" first="Katherine H O" last="Deane">Katherine H O. Deane</name>
<affiliation wicri:level="1">
<mods:affiliation>University of East Anglia, Norwich, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of East Anglia, Norwich</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wheatley, Keith" sort="Wheatley, Keith" uniqKey="Wheatley K" first="Keith" last="Wheatley">Keith Wheatley</name>
<affiliation wicri:level="4">
<mods:affiliation>Cancer Research UK Clinical Trials Unit, School of Cancer Sciences, University of Birmingham</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
<orgName type="university">Université de Birmingham</orgName>
</affiliation>
</author>
<author>
<name sortKey="Ives, Natalie" sort="Ives, Natalie" uniqKey="Ives N" first="Natalie" last="Ives">Natalie Ives</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">ISTEX</idno>
<idno type="RBID">ISTEX:76F28FD69674A9085206DEA896CE201F5FDB97DD</idno>
<date when="2012" year="2012">2012</date>
<idno type="doi">10.1136/bmj.e5004</idno>
<idno type="url">https://api.istex.fr/document/76F28FD69674A9085206DEA896CE201F5FDB97DD/fulltext/pdf</idno>
<idno type="wicri:Area/Main/Corpus">001719</idno>
<idno type="wicri:Area/Main/Curation">001483</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title level="a">Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis</title>
<author>
<name sortKey="Tomlinson, Claire L" sort="Tomlinson, Claire L" uniqKey="Tomlinson C" first="Claire L" last="Tomlinson">Claire L. Tomlinson</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
<affiliation wicri:level="1">
<mods:affiliation>E-mail: c.l.smith.1@bham.ac.uk</mods:affiliation>
<country wicri:rule="url">Royaume-Uni</country>
</affiliation>
</author>
<author>
<name sortKey="Patel, Smitaa" sort="Patel, Smitaa" uniqKey="Patel S" first="Smitaa" last="Patel">Smitaa Patel</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Meek, Charmaine" sort="Meek, Charmaine" uniqKey="Meek C" first="Charmaine" last="Meek">Charmaine Meek</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Herd, Clare P" sort="Herd, Clare P" uniqKey="Herd C" first="Clare P" last="Herd">Clare P. Herd</name>
<affiliation wicri:level="4">
<mods:affiliation>School of Clinical and Experimental Medicine, College of Medicine and Dental Sciences, University of Birmingham</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
<orgName type="university">Université de Birmingham</orgName>
</affiliation>
</author>
<author>
<name sortKey="Clarke, Carl E" sort="Clarke, Carl E" uniqKey="Clarke C" first="Carl E" last="Clarke">Carl E. Clarke</name>
<affiliation wicri:level="4">
<mods:affiliation>School of Clinical and Experimental Medicine, College of Medicine and Dental Sciences, University of Birmingham</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
<orgName type="university">Université de Birmingham</orgName>
</affiliation>
<affiliation wicri:level="3">
<mods:affiliation>Department of Neurology, Sandwell and West Birmingham Hospitals NHS Trust, City Hospital, Birmingham</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
<wicri:orgArea>Department of Neurology, Sandwell and West Birmingham Hospitals NHS Trust, City Hospital</wicri:orgArea>
</affiliation>
</author>
<author>
<name sortKey="Stowe, Rebecca" sort="Stowe, Rebecca" uniqKey="Stowe R" first="Rebecca" last="Stowe">Rebecca Stowe</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Shah, Laila" sort="Shah, Laila" uniqKey="Shah L" first="Laila" last="Shah">Laila Shah</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Sackley, Catherine" sort="Sackley, Catherine" uniqKey="Sackley C" first="Catherine" last="Sackley">Catherine Sackley</name>
<affiliation wicri:level="1">
<mods:affiliation>University of East Anglia, Norwich, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of East Anglia, Norwich</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Deane, Katherine H O" sort="Deane, Katherine H O" uniqKey="Deane K" first="Katherine H O" last="Deane">Katherine H O. Deane</name>
<affiliation wicri:level="1">
<mods:affiliation>University of East Anglia, Norwich, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>University of East Anglia, Norwich</wicri:regionArea>
</affiliation>
</author>
<author>
<name sortKey="Wheatley, Keith" sort="Wheatley, Keith" uniqKey="Wheatley K" first="Keith" last="Wheatley">Keith Wheatley</name>
<affiliation wicri:level="4">
<mods:affiliation>Cancer Research UK Clinical Trials Unit, School of Cancer Sciences, University of Birmingham</mods:affiliation>
<country>Royaume-Uni</country>
<placeName>
<settlement type="city">Birmingham</settlement>
<region type="country">Angleterre</region>
<region type="région" nuts="1">Midlands de l'Ouest</region>
</placeName>
<orgName type="university">Université de Birmingham</orgName>
</affiliation>
</author>
<author>
<name sortKey="Ives, Natalie" sort="Ives, Natalie" uniqKey="Ives N" first="Natalie" last="Ives">Natalie Ives</name>
<affiliation wicri:level="1">
<mods:affiliation>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT, UK</mods:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Birmingham Clinical Trials Unit, University of Birmingham, Birmingham B15 2TT</wicri:regionArea>
</affiliation>
</author>
</analytic>
<monogr></monogr>
<series>
<title level="j">BMJ : British Medical Journal</title>
<title level="j" type="abbrev">BMJ</title>
<idno type="eISSN">1756-1833</idno>
<imprint>
<publisher>British Medical Journal Publishing Group</publisher>
<date>2012</date>
<biblScope unit="volume">345</biblScope>
</imprint>
</series>
<idno type="istex">76F28FD69674A9085206DEA896CE201F5FDB97DD</idno>
<idno type="DOI">10.1136/bmj.e5004</idno>
<idno type="href">bmj-345-bmj-e5004.pdf</idno>
<idno type="ArticleID">tomc002253</idno>
<idno type="local">bmj;345/aug06_1/e5004</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
<langUsage>
<language ident="en">en</language>
</langUsage>
</profileDesc>
</teiHeader>
<front>
<div type="abstract">Objective To assess the effectiveness of physiotherapy compared with no intervention in patients with Parkinson’s disease. Design Systematic review and meta-analysis of randomised controlled trials. Data sources Literature databases, trial registries, journals, abstract books, and conference proceedings, and reference lists, searched up to the end of January 2012. Review methods Randomised controlled trials comparing physiotherapy with no intervention in patients with Parkinson’s disease were eligible. Two authors independently abstracted data from each trial. Standard meta-analysis methods were used to assess the effectiveness of physiotherapy compared with no intervention. Tests for heterogeneity were used to assess for differences in treatment effect across different physiotherapy interventions used. Outcome measures were gait, functional mobility and balance, falls, clinician rated impairment and disability measures, patient rated quality of life, adverse events, compliance, and economic analysis outcomes. Results 39 trials of 1827 participants met the inclusion criteria, of which 29 trials provided data for the meta-analyses. Significant benefit from physiotherapy was reported for nine of 18 outcomes assessed. Outcomes which may be clinically significant were speed (0.04 m/s, 95% confidence interval 0.02 to 0.06, P<0.001), Berg balance scale (3.71 points, 2.30 to 5.11, P<0.001), and scores on the unified Parkinson’s disease rating scale (total score −6.15 points, −8.57 to −3.73, P<0.001; activities of daily living subscore −1.36, −2.41 to −0.30, P=0.01; motor subscore −5.01, −6.30 to −3.72, P<0.001). Indirect comparisons of the different physiotherapy interventions found no evidence that the treatment effect differed across the interventions for any outcomes assessed, apart from motor subscores on the unified Parkinson’s disease rating scale (in which one trial was found to be the cause of the heterogeneity). Conclusions Physiotherapy has short term benefits in Parkinson’s disease. A wide range of physiotherapy techniques are currently used to treat Parkinson’s disease, with little difference in treatment effects. Large, well designed, randomised controlled trials with improved methodology and reporting are needed to assess the efficacy and cost effectiveness of physiotherapy for treating Parkinson’s disease in the longer term.</div>
</front>
</TEI>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001483 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Curation/biblio.hfd -nk 001483 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonV1
   |flux=    Main
   |étape=   Curation
   |type=    RBID
   |clé=     ISTEX:76F28FD69674A9085206DEA896CE201F5FDB97DD
   |texte=   Physiotherapy intervention in Parkinson’s disease: systematic review and meta-analysis
}}

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 18:06:51 2016. Site generation: Wed Mar 6 18:46:03 2024